Press enter to see results or esc to cancel.

CorWave

CorWave is a medical device company developing an implantable heart pump (Left Ventricular Assist Devices, LVADs) based on breakthrough technology, the wave membrane pump. The membrane is able to generate a natural pulse, replicating the blood flow and pressure characteristics of the patient’s native heart. CorWave’s novel membrane pump technology is being developed to reduce …

Continue Reading

Anaconda Biomed

Anaconda Biomed is developing the next generation of catheters to perform safely and efficiently mechanical thrombectomies. Its flagship product is the ANA (Advanced Neurovascular Access) Catheter System, which consists of unique, funnel-shaped delivery and aspiration catheters to be used in combination with a stent retriever. When deployed, the funnel self-expands and directly conforms to the …

Continue Reading

MedLumics

MedLumics develops a radiofrequency cardiac ablation catheter called AblaView, which allows the treatment of atrial fibrillation (AF) in real time using an optical image guidance system. Said treatment relies on a minimally-invasive surgical technique that involves scarring or destroying tissue in the heart using radiofrequency energy to disrupt faulty electrical signals causing the arrhythmia. It …

Continue Reading

TriCares

TriCares is a medical device company behind Topaz, an innovative device designed specifically to help patients suffering from severe tricuspid regurgitation without the need for open heart surgery. The Topaz device is implanted in a minimally invasive procedure through the patient’s femoral vein. It is designed specifically to fit the tricuspid valve anatomy and thus …

Continue Reading

Ultromics

Born at the University of Oxford, Ultromics provides autonomous echocardiography analysis through its AI solutions, empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. The company’s cloud-based services, EchoGo and EchoGo Pro, fully automates the pathway to diagnosis of coronary artery disease, heart failure and amyloidosis — providing near-instant reports for clinicians without …

Continue Reading

Methinks

Methinks has developed medical imaging software that detects cerebral artery occlusions and hemorrhages using artificial intelligence without the need for a CT scan with contrast. The company’s tech reduces time-to-treatment, enabling radiologists to communicate with hospitals, stroke units, and healthcare professionals. While Methinks is currently focusing on strokes, the second cause of death and a …

Continue Reading